Back to search

Axol Bioscience Ltd

08340031

active
Private Limited Company
england wales
Companies House
1 outstanding charge
Health Score
73 / 100

Some Concerns

25/30
Filing
10/30
Financial
38/40
Risk
  • No accounts filed in last 18 months (-5)
  • Current liabilities exceed current assets (-10)
  • 1 outstanding charge (-2)

Details

MEDITRINA BUILDING BABRAHAM BABRAHAM RESEARCH CAMPUS, CAMBRIDGE, CB22 3AT
Incorporated 21/12/2012

Compliance

Last accounts

31/12/2024

small

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 24/07/2025

Due 07/08/2026

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Dr Derek John Trezise

director · Since 27/05/2020

RESEARCH SCIENTIST

BRITISH · ENGLAND · Age 58

Also on 3 other boards

Mr Liam Mark Taylor

director · Since 03/09/2020

CHIEF EXECUTIVE

AUSTRALIAN · WALES · Age 49

Also on 2 other boards

Dr Harry Thomas Stratford

director · Since 16/03/2021

EXECUTIVE

BRITISH · SCOTLAND · Age 55

Also on 3 other boards

Mr Oliver Richardson

director · Since 31/10/2022

FINANCE DIRECTOR

ENGLISH · ENGLAND · Age 31

Also on 2 other boards

Persons with Significant Control

Censo Biotechnologies Ltd

75–100% shares
75–100% votes

Roslin Innovation Centre, Charnock Bradley Building, Midlothian, EH25 9RG

Reg: Sc348293 · Companies House, Registrar Of Companies For Scotland · Private Limited Company

Notified 16/03/2021

Former PSCs

Dr Yichen Shi

Ceased 16/03/2021

Charges1 outstanding

Charge
outstanding

BROADOAK FUND VI, L.P. (AS SECURITY TRUSTEE)

Created 24/12/2025Registered 31/12/2025

CompanyRankvs 320+ SIC 72110 peers
77

Financial strength94th percentile among SIC peers · 24/25
Employees97th percentile among SIC peers · 15/15
LiquidityCurrent ratio 3.97× · 20/20
Longevity13 years trading (max 15) · 13/15
Filing complianceAll filings up to date · 15/15
Outstanding charges -10
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Labgenius Limited
89
9Nuclera Ltd
88
10Aparito Limited
87
32Axol Bioscience Ltd
87
How is this score calculated?
Financial strength24/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees15/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity13/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2018

Net Worth

£1.7M

Balance sheet strength

Cash

£817k

Cash in the bank

Net Current Assets

£1.5M

Working capital

Current Assets

£2.0M

Current Liabilities

£493k

Fixed Assets

£239k

Debtors

£876k

24avg. employees

Balance Sheet

Intangible assets£105k
Assets less current liabilities£1.7M
Signed by 2018-01-01Prepared with Companies House

EstimatesDerived

YearCurrent Ratio
20183.97

Derived from filed accounts. Not audited figures.